Skip to main content
Caplight Logo









Enorna Biotechnology

Enorna Biotechnology

Private
ChinaHealthcare & Life Scienceshttps://enorna.com

Company Overview

Enorna Biotechnology operates in Healthcare & Life Sciences and is based in China.

Enorna Biotechnology is an mRNA CRDMO company that provides end-to-end solutions from sequence design to commercial GMP manufacturing of plasmid, mRNA, and LNP drug products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Enorna Biotechnology Comparables

Compare Enorna Biotechnology with similar companies based on industry and business-model similarity.

Enorna Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kudo Biotechnology
92%
Vernal Biosciences
83%
ARCALIS, Inc.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Enorna Biotechnology Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Enorna Biotechnology. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingOct 29, 2026

    Enorna receives $15M across angel and Pre-A rounds in China, jointly led by Addor Capital and Tenykin Capital with participation from Lucion and Nanjing Innovation Capital Group to upgrade its LNP delivery platform, expand GMP manufacturing capacity and develop overseas business.

Book a demo to see all news

For institutional investors. Book with your work email.

Enorna Biotechnology Filings

Explore SEC and related filing metadata, where available.

Enorna Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Enorna Biotechnology's valuation, stock price, and market status.

Is Enorna Biotechnology a public or private company?

Enorna Biotechnology is a private company.

What is the current stock price of Enorna Biotechnology?

Enorna Biotechnology is a private company, so its shares have no public market price. Caplight tracks Enorna Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Enorna Biotechnology worth (valuation)?

Valuation information for Enorna Biotechnology is not publicly available.

Can I buy Enorna Biotechnology stock?

Enorna Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Enorna Biotechnology's last funding round?

Funding round information for Enorna Biotechnology is not publicly available.

Who are the main investors in Enorna Biotechnology?

Investor information for Enorna Biotechnology is not publicly disclosed.

Will Enorna Biotechnology IPO soon?

No public IPO plans have been announced for Enorna Biotechnology.

How can I track Enorna Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in Enorna Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersChina
Employee Range3
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?